Use of Immun Checkpoint Inhibitor Ipilimumab in Renal Transplant Patients with Advanced Cancer: Is Risk/Benefit Ratio Dilemma?


Creative Commons License

Anapalı M., Balkan E.

New Trends in Medicine Sciences, cilt.1, sa.2, ss.137-145, 2020 (Hakemli Dergi)